These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9512081)

  • 21. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
    Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of apomorphine induced behavioral sensitization in rats treated with escitalopram.
    Farhan M; Parveen M
    Pak J Pharm Sci; 2019 Jan; 32(1):197-203. PubMed ID: 30772809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
    Ainsworth K; Smith SE; Sharp T
    J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.
    Brennan JA; Graf R; Grauer SM; Navarra RL; Pulicicchio CM; Hughes ZA; Lin Q; Wantuch C; Rosenzweig-Lipson S; Pruthi F; Lai M; Smith D; Goutier W; van de Neut M; Robichaud AJ; Rotella D; Feenstra RW; Kruse C; Broqua P; Beyer CE; McCreary AC; Pausch MH; Marquis KL
    J Pharmacol Exp Ther; 2010 Jan; 332(1):190-201. PubMed ID: 19828876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1.
    Sur C; Betz H; Schloss P
    J Neurochem; 1998 Jun; 70(6):2545-53. PubMed ID: 9603221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of apomorphine-induced behavioral sensitization in rats pretreated with fluoxetine.
    Haleem DJ; Farhan M
    Behav Pharmacol; 2015 Feb; 26(1-2):159-66. PubMed ID: 24755891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of pinoline on the 5-hydroxytryptamine transporter: competitive interaction with [3H] citalopram.
    Pähkla R; Rägo L; Callaway JJ; Airaksinen MM
    Pharmacol Toxicol; 1997 Mar; 80(3):122-6. PubMed ID: 9101584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic treatment with antidepressant drugs: potentiation of apomorphine-induced aggressive behaviour in rats.
    Maj J; Mogilnicka E; Kordecka A
    Neurosci Lett; 1979 Aug; 13(3):337-41. PubMed ID: 575199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.
    Chenu F; David DJ; Leroux-Nicollet I; Le Maître E; Gardier AM; Bourin M
    J Psychiatry Neurosci; 2008 Nov; 33(6):541-50. PubMed ID: 18982177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in [3H]citalopram binding in cerebral cortex after antidepressant treatment in monoamine-impaired rats.
    Pruus K; Rudissaar R; Skrebuhhova T; Allikmets L; Matto V
    Boll Chim Farm; 2000; 139(1):41-5. PubMed ID: 10829552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
    Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
    PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
    Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    Sánchez C; Hyttel J
    Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
    Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.